[The therapy of advanced breast carcinoma in men].

Dtsch Med Wochenschr

Klinik für Innere Medizin Küchwald, Städtische Kliniken Chemnitz.

Published: January 1992

Four men (mean age 50 [42-57] years) were treated for advanced carcinoma of the breast, two of them by chemotherapy alone. Survival time in the latter two after start of the chemotherapy was 5 and 8 months, respectively. The third patient received both hormone and chemotherapy from the start because of unfavourable prognostic criteria. For 15 months the tumour stage remained unchanged until the patient developed incomplete paraplegia which improved greatly after decompression laminectomy. This has been followed for four months by renewed hormonal and chemotherapy. The fourth patient received tamoxifen for seven months, with intrapleural administration of cytostatic agents and finally pleurectomy for recurrent malignant pleural effusions. For 4 months he has again been receiving hormonal and chemotherapy. These cases illustrate that if there are unfavourable prognostic criteria chemotherapy should be added to conventional hormone therapy.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2008-1062295DOI Listing

Publication Analysis

Top Keywords

patient received
8
unfavourable prognostic
8
prognostic criteria
8
hormonal chemotherapy
8
chemotherapy
6
months
5
[the therapy
4
therapy advanced
4
advanced breast
4
breast carcinoma
4

Similar Publications

The introduction of devices for endovascular dialysis access creation (WavelinQ and Ellipsys) offers practitioners more options for access management in dialysis patients. Especially in terms of reducing the usage of central venous catheters, a native fistula is desirable as an initial dialysis access. We present a case in which a failed WavelinQ type fistula was reactivated using the Ellipsys procedure on the same arm.

View Article and Find Full Text PDF

The purpose of the present study was to evaluate and compare the clinical outcomes of two groups of patients subject to bi-cruciate retaining (BCR) or posterior-stabilized (PS) implants. It was hypothesized that patients treated with BCR prostheses would present higher flexion and better clinical and functional results than those treated with PS implants. This prospective study included thirty-two patients treated for primary knee osteoarthritis and assigned to two matched groups for their demographic characteristics and comorbidities.

View Article and Find Full Text PDF

The objectives were to evaluate the effectiveness and safety of a single preoperative dose of intravenous tranexamic acid (TXA) in reducing perioperative blood loss and requirement for transfusion in patients undergoing hip hemiarthroplasty for femoral neck fracture. A double-blind randomized controlled trial was conducted in 140 patients with hip fracture. After randomization, 68 patients received a single dose of 1 gr of intravenous TXA at the start of the surgery (TXA group), and 72 received a placebo treatment (placebo group).

View Article and Find Full Text PDF

Large-diameter heads (LDHs) in total hip arthroplasty (THA) enhance range of motion but require thinner liners. Monoblock acetabular components with ceramic liners could reduce liner fracture risks during modular acetabular component assembly. This study aims to confirm the safety and clinical performance of the monoblock Maxera Cup in THA.

View Article and Find Full Text PDF

Aim: Chronic hepatitis C virus infections can lead to liver fibrosis. Appropriate treatment of chronic hepatitis C may result in significant fibrosis reversal. The best method to assess liver fibrosis is an invasive hepatic biopsy.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!